MARKET

ICUI

ICUI

ICU Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

207.50
-10.69
-4.90%
After Hours: 207.50 0 0.00% 16:00 02/26 EST
OPEN
218.19
PREV CLOSE
218.19
HIGH
218.19
LOW
199.03
VOLUME
242.80K
TURNOVER
--
52 WEEK HIGH
236.51
52 WEEK LOW
158.01
MARKET CAP
4.35B
P/E (TTM)
54.89
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Global Pressure Sensor for Medical Market 2020 Industry Key Player, Trend and Segmented Data, Demand and Forecast by 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- The most recent report namely Global Pressure Sensor for Medical Market 2020 by Manufacturers, Regions, Type and...
CDN Newswire · 22h ago
10-K: ICU MEDICAL INC/DE
Edgar Online - (EDG = 10Q, 10K) · 2d ago
DJ ICU Medical, Inc. CEO Vivek Jain on Q4 2020 Results -- Earnings Call Transcript >ICUI
Dow Jones · 2d ago
DJ ICU Medical Is Maintained at Outperform by Raymond James
Dow Jones · 2d ago
DJ ICU Medical Price Target Raised to $245.00/Share From $235.00 by Raymond James
Dow Jones · 2d ago
Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI), Acceleron Pharma (XLRN) and Intellia Therapeutics (NTLA)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ICU Medical (ICUI), Acceleron Pharma (XLRN) and Intellia
SmarterAnalyst · 2d ago
Global Intravenous Sets Market Gross Earning And Emerging Growth Opportunity 2031
Feb 26, 2021 (WiredRelease via Comtex) -- The latest research report provides a complete assessment of the Global Intravenous Sets market for the forecast...
marketresearch.biz · 2d ago
--Analyst Actions: Raymond James Adjusts Price Target on ICU Medical to $245 From $235, Maintains Outperform Rating
MT Newswires · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICUI. Analyze the recent business situations of ICU Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICUI stock price target is 237.00 with a high estimate of 240.00 and a low estimate of 235.00.
EPS
Institutional Holdings
Institutions: 448
Institutional Holdings: 21.89M
% Owned: 104.34%
Shares Outstanding: 20.98M
TypeInstitutionsShares
Increased
86
1.08M
New
58
-32.28K
Decreased
104
907.87K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Chairman/Chief Executive Officer/Director
Vivek Jain
Chief Financial Officer/Treasurer
Brian Bonnell
Chief Operating Officer
Christian Voigtlander
Vice President/General Counsel/Secretary
Virginia Sanzone
Vice President/General Manager
Daniel Woolson
Lead Director/Independent Director
David Greenberg
Director
George Lopez
Independent Director
Donald Abbey
Independent Director
Elisha Finney
Independent Director
David Hoffmeister
Independent Director
Robert Swinney
  • Dividends
  • Splits
  • Insider Activity
No Data
About ICUI
ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.

Webull offers kinds of ICU Medical Inc stock information, including NASDAQ:ICUI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICUI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICUI stock methods without spending real money on the virtual paper trading platform.